A case of multi-agent drug resistant choriocarcinoma treated with Pembrolizumab
Sign Up to like & getrecommendations! Published in 2020 at "Gynecologic Oncology Reports"
DOI: 10.1016/j.gore.2020.100574
Abstract: Highlights • High-risk multi-agent drug resistant GTN is a life threatening disease.• Majority of choriocarcinomas show intense PD-L1 immunoreactivity.• Pembrolizumab increases antitumor activity.• Effectiveness of Pembrolizumab in treating patients with high-risk multi-agent drug resistant GTN. read more here.
Keywords: case multi; resistant choriocarcinoma; multi agent; drug resistant ... See more keywords